Jason Wild

Jason Wild

Chairman chez TERRASCEND CORP.

Fortune : 5 M $ au 31/03/2024

51 ans
Finance
Health Technology
Health Services

Profil

Jason Garrett Wild is currently the Executive Chairman at Terrascend Corp.
and the Director at Vitruvias Therapeutics, Inc. He is also a Director at NETA NJ LLC.
Previously, he held the position of Chairman at Arbor Pharmaceuticals LLC from 2010 to 2021 and Director at Vensun Pharmaceuticals, Inc. from 2012 to 2019.
Mr. Wild started his career in 2003 as the President & Chief Investment Officer at JW Asset Management LLC and later became the Chief Investment Officer.
He is also an Advisor at Entourage Effect Capital LLC.
Mr. Wild completed his undergraduate degree from the University of Wisconsin in 1994.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
25/03/2024 2 872 428 ( 0,99% ) 5 M $ 31/03/2024

Postes actifs de Jason Wild

SociétésPosteDébut
TERRASCEND CORP. Chairman 11/12/2017
Chief Executive Officer 01/11/2003
Director/Board Member 10/01/2018
NETA NJ LLC Director/Board Member -
Consultant / Advisor -
President 01/11/2003
Tous les postes actifs de Jason Wild

Anciens postes connus de Jason Wild

SociétésPosteFin
Chairman 30/11/2021
Director/Board Member 30/11/2019
Voir l'expérience en détail de Jason Wild

Formation de Jason Wild

University of Wisconsin Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Jason Wild

Relations

65

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
TERRASCEND CORP.

Process Industries

Entreprise privées7

Health Technology

Health Technology

Health Services

Finance

Finance

Finance

NETA NJ LLC

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Jason Wild